-
Patients Denied Care, Then Approved Later? Federal Watchdog Raises Medicare Advantage Concerns
Thursday, June 11, 2026 - 8:20am | 745Read More...Federal investigators raised concerns about how Medicare Advantage plans handle requests for post-hospital recovery care, finding that many denials were later overturned on appeal. Two reports from the Office of Inspector General at the Department of Health and Human Services earlier this month...
-
UnitedHealth Stock Jumps After Q1 Beat — Here's What Execs Say Drove It
Tuesday, April 21, 2026 - 2:39pm | 740Read More...UnitedHealth Group (NYSE:UNH) shares jumped more than 8% on Tuesday after the health insurance giant delivered a strong first-quarter earnings beat and raised its full-year profit outlook — signaling that a prolonged period of elevated medical costs may finally be turning the corner. UNH stock is...
-
UnitedHealth Q1 Preview: Buffett's Health Insurance Bet Faces 'Crucial' Guidance Moment
Monday, April 20, 2026 - 1:30pm | 1025Read More...Health insurance giant UnitedHealth Group Inc (NYSE:UNH) could show signs of a continued turnaround effort when the company reports first-quarter financial results Tuesday before market open. Here are the earnings estimates, what experts are saying before the report and the key items to watch....
-
UnitedHealth Stock Sell-Off Screams 'Buying Opportunity'
Wednesday, January 28, 2026 - 3:43pm | 438Read More...Following Tuesday's sharp 20% drop, Cantor Fitzgerald analysts labeled the decline in UnitedHealth Group, Inc. (NYSE:UNH) shares as a buying opportunity. UnitedHealth stock plummeted following a disappointing 2027 Medicare Advantage Advance Notice and a fourth quarter earnings report that met...
-
Trump Just Shocked Medicare Stocks — Will Seth Klarman Seize This Moment?
Tuesday, January 27, 2026 - 12:55pm | 553Read More...The Medicare Advantage trade just got repriced—by Washington. Donald Trump‘s administration proposed 0.09% rate hike for Medicare Advantage plans in 2027, a fraction of Wall Street's 4%–6% expectations, triggering a sharp selloff across the sector. Stocks of managed-care giants like CVS...
-
UnitedHealth Heads Into Q4 Earnings As Elevated Medical Costs Loom — Is Stability In Sight?
Tuesday, January 27, 2026 - 4:34am | 515Read More...With health insurer UnitedHealth Group Inc. (NYSE:UNH) set to report its fourth-quarter results on Tuesday, investors remain focused on elevated medical costs, which weighed on the company’s margins and profitability throughout the past year. Are Medical Costs Set To Normalize? During the...
-
Clover Beats Q2 Estimates, Stock Drops: Here Are The Details
Tuesday, August 5, 2025 - 5:16pm | 374Read More...Healthcare technology company Clover Health Investments Corp. (NASDAQ:CLOV) is trading lower after reporting second-quarter financial results after market close on Tuesday. CLOV is seeing a decline in price after-hours. Track it now here. What Happened: The company reported second-quarter revenue...
-
Health Care Stocks Like UnitedHealth, CVS Tank On Wednesday: Here's Why
Wednesday, May 21, 2025 - 5:41pm | 430Read More...Health care stocks including UnitedHealth Group, Inc. (NYSE:UNH), Elevance Health, Inc. (NYSE:ELV) and CVS Health Corp. (NYSE:CVS) are tanking in Wednesday's extended trading after the Centers for Medicare & Medicaid Services (CMS) announced a significant expansion of its auditing efforts for...
-
UnitedHealth CEO Says High Cost Of US Health Care 'Simply Not Sustainable'
Thursday, April 17, 2025 - 12:00pm | 480Read More...UnitedHealth Group Inc. (NYSE:UNH) shares were down by more than 21% Thursday, the stock's worst drop since 1998, after the company reported worse-than-expected quarterly results due in part to the rising cost of health care in the U.S. CEO Andrew Witty provided additional insights on the company's...
-
Healthcare Investors Bet On Easier Medicare Rules Under Potential Trump Administration
Wednesday, July 17, 2024 - 4:09pm | 487Read More...Healthcare investors are expecting Republican presidential nominee Donald Trump to ease regulations on Medicare Advantage if the former president wins and returns to the White House. Under the Biden administration, the Centers for Medicare & Medicaid Services has hardened its stance on the...
-
Clover Health Q2 Takeaways: Revenue Beat, Guidance Raise And Clover Assistant Growth
Wednesday, August 11, 2021 - 6:03pm | 236Read More...Health care technology company Clover Health (NASDAQ: CLOV) reported second-quarter earnings Wednesday afternoon. What Happened: Clover Health had revenue of $412 million in the second quarter, up 140% year-over-year. The revenue total beat analysts’ estimate of $205.4 million for the quarter...
-
IPO Preview: WalkMe, Atai Life Sciences Highlight Week Of Many Offerings
Monday, June 14, 2021 - 5:21pm | 1056Read More...This week’s IPO lineup could feature a double digit number of companies hitting the public. Here is a look at some of the largest and most high profile companies going public this week. AMTD Digital: Asian digital solutions platform AMTD Digital (NYSE: HKD) offers risk solutions and digital...
-
UnitedHealth Group Highlights Technology, Areas Targeted For Improvement At Investor Day
Wednesday, November 28, 2018 - 12:37pm | 503Read More...UnitedHealth Group Inc. (NYSE: UNH) hosted an investor day Tuesday highlighting the company’s growth, special technologies and 2019 guidance. The Analysts Morgan Stanley analyst Zack Sopcak reiterated an Overweight rating on UnitedHealth and $308 price target. Wells Fargo analyst Peter Costa...
-
Don't Expect Failed Humana Deal To Quash Aetna's Desire For M&A
Wednesday, June 28, 2017 - 12:47pm | 345Read More...Analysts at Citi initiates coverage of Aetna Inc (NYSE: AET) with a Buy rating, $180 price target and named to the firm's "Citi Focus List." Aetna should be viewed as a "strong diversified health insurer" that is also well positioned to gain share within the government segment and has "stable...
-
Putting Failed Aetna Deal Behind It, Humana Is Refocused On Growth; Analyst Upgrades The Stock
Friday, June 9, 2017 - 10:40am | 360Read More...Argus in a note released on Friday upgraded shares of Humana Inc (NYSE: HUM), with the upgrade premised on the belief that the company has strong growth prospects as an independent company following the termination of its merger agreement with Aetna Inc (NYSE: AET). The Annulled Deal Aetna...















